STOCK TITAN
  1. Home
  2. Sec-filings
  3. MTVA
  4. [EFFECT] MetaVia Inc. SEC Filing

[EFFECT] MetaVia Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: January 15, 2026 9:00 A.M.
Form: S-1
CIK: 0001638287
Company Name: MetaVia Inc.
File Number: 333-292581

Source: View Original Filing on SEC EDGAR

MetaVia Inc

NASDAQ:MTVA

View MTVA Stock Overview →

MTVA Rankings

#6685 Ranked by Market Cap
N/A Ranked by Dividends

MTVA Latest News

Mar 4, 2026
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
Feb 17, 2026
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference
Feb 13, 2026
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041
Feb 4, 2026
MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel
Jan 16, 2026
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option

MTVA Latest SEC Filings

Jan 27, 2026
[Form 4] MetaVia Inc. Insider Trading Activity
Jan 27, 2026
[8-K] MetaVia Inc. Reports Material Event
Jan 27, 2026
[Form 4] MetaVia Inc. Insider Trading Activity
Jan 16, 2026
[8-K] MetaVia Inc. Reports Material Event
Jan 16, 2026
[424B4] MetaVia Inc. Prospectus Filed Pursuant to Rule 424(b)(4)

MTVA Stock Data

5.14M
1.37M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE